Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Autosomal recessive hearing loss. 41-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal recessive: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 75 | 75 |
|
Beacon Ashkenazi Jewish Male Carrier Screening Panel Fulgent Genetics United States | 145 | 41 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Familial Hypertriglyceridemia NGS Panel Fulgent Genetics United States | 20 | 15 |
|
Beacon Ashkenazi Jewish Female Carrier Screening Panel Fulgent Genetics United States | 148 | 42 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Ashkenazi Jewish Male Carrier Screening Panel Fulgent Genetics United States | 145 | 41 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 249 | 181 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.